Treventis was represented at the 50th Society for Neuroscience Conference in Chicago, Illinois, one of the world’s largest conferences dedicated to brain research. Among the topics addressed in Chicago: mouse models of Alzheimer’s disease and other neurodegenerative disorders; seeding (Tau & Aβ) models; and new developments in the therapeutic landscape for AD. Treventis has an active anti-tau/Aβ program aiming to halt disease progression (including mechanisms associated with seeding) in AD.